1
11
02:17
Man Beats Florist To Death For Posting A Photo Of A Floral Arrangement The Killer's Wife Created
1
11
0
Smirking drug CEO, Martin Shkreli, antagonizes lawmakers after pleading the Fifth
01:14
Dude Is Charging His Wedding Guests 450 Dollars Because He Spent Too Much On The Event
0
10
0
01:20
Woman Sets Her Man And Herself On Fire During An Argument
0
1
0
00:30
Two Teens Murdered On Christmas Eve By A Degenerate in Alabama
0
2
0
02:07
Biden's Legacy...A Massive Surge In Homelessness
0
0
0
01:43
Disturbing Body-Cam Footage Shows A New York Correctional Officer Beat A Handcuffed Man To Death
2
2
0
01:18
Kamala Thinks She's Scoring Brownie Points By Saying She Celebrates Kwanzaa, Let's Remind Everyone What That Is
0
5
0
(AP) - Pharmaceutical chief Martin Shkreli has arrived at a hearing where U.S. lawmakers want to hear from about severe hikes for a drug sold by a company that he acquired.But it's unlikely the former CEO of Turing Pharmaceuticals will answer questions in his appearance Thursday before the House Oversight and Government Reform Committee. Shkreli, widely scorned for hiking the price of a long-established and potentially lifesaving drug by more than 5,000 percent, has said he's exercising his Fifth Amendment right against self-incrimination. The 32-year-old Shkreli faces separate criminal charges of securities fraud related to another drug company. Also going before lawmakers is the interim CEO of Canada's largest drugmaker, Valeant Pharmaceuticals. Both companies have sharply raised prices for drugs taken by patients with heart problems, AIDS, cancer and other conditions.
